Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
04 March 2025 - 8:14AM
Edgar (US Regulatory)
Free Writing Prospectus
Filed pursuant to Rule 433
Registration No. 333-285481
Term Sheet
(To preliminary prospectus supplement, dated
March 3, 2025,
and prospectus, dated March 3, 2025)
$750,000,000
4.400% Notes due 2030 (the “Notes”)
|
|
|
| Issuer: |
|
CME Group Inc. |
|
|
| Security Type: |
|
SEC Registered Senior Unsecured Notes |
|
|
| Trade Date: |
|
March 3, 2025 |
|
|
| Settlement Date**: |
|
March 10, 2025 (T+5) |
|
|
| Principal Amount: |
|
$750,000,000 |
|
|
| Maturity Date: |
|
March 15, 2030 |
|
|
| Interest Rate Per Annum: |
|
4.400% |
|
|
| Interest Payment Dates: |
|
Semiannually, on March 15 and September 15 of each year |
|
|
| First Interest Payment Date: |
|
September 15, 2025 (long first coupon) |
|
|
| Optional Redemption: |
|
Make-whole redemption at any time prior to February 15, 2030 (one month prior to the maturity date of the notes) at a discount rate equal to the Treasury Rate (as defined in the preliminary prospectus supplement) plus 10 bps.
Redemption at par at any time commencing on February 15, 2030. |
|
|
| Public Offering Price: |
|
99.573% of the principal amount |
|
|
| Proceeds to CME Group Inc. (before estimated expenses, after underwriting discount): |
|
$742,297,500 |
|
|
| Treasury Benchmark: |
|
UST 4.00% due February 28, 2030 |
|
|
| Treasury Benchmark Price and Yield: |
|
100-00+ / 3.996% |
|
|
| Re-offer Spread vs. Treasury Benchmark: |
|
50 bps |
|
|
| Yield to Maturity: |
|
4.496% |
|
|
| Mandatory Offer to Repurchase Notes: |
|
In the event of a “Change of Control Triggering Event” (as defined in the preliminary prospectus supplement) at 101% of the principal amount, plus accrued and unpaid interest. |
|
|
| Day Count: |
|
30/360 |
|
|
| Payment Business Days: |
|
New York |
|
|
| Payment Convention: |
|
Following, Unadjusted |
|
|
| Minimum Denomination / Multiples: |
|
$2,000 / $1,000 |
|
|
| CUSIP / ISIN: |
|
12572Q AL9/ US12572QAL95 |
1
|
|
|
| Ratings (Moody’s/ S&P / Fitch)*: |
|
Aa3 / AA- / AA- |
|
|
| Joint Book-Running Managers: |
|
Barclays Capital Inc. J.P. Morgan Securities
LLC Wells Fargo Securities, LLC |
|
|
BMO Capital Markets Corp. |
|
|
BofA Securities, Inc. |
|
|
Citigroup Global Markets Inc. |
|
|
Lloyds Securities Inc. |
|
|
Loop Capital Markets LLC |
|
|
MUFG Securities Americas Inc. |
|
|
TD Securities (USA) LLC |
|
|
| Co-Managers: |
|
Academy Securities, Inc. |
|
|
BNP Paribas Securities Corp. |
|
|
Deutsche Bank Securities Inc. |
|
|
Goldman Sachs & Co. LLC |
|
|
Huntington Securities, Inc. |
|
|
Siebert Williams Shank & Co., LLC |
|
|
U.S. Bancorp Investments, Inc. |
| * |
Note: A securities rating is not a recommendation to buy, sell, or hold securities and may be subject to
revision or withdrawal at any time. |
| ** |
It is expected that delivery of the Notes will be made against payment therefor on or about March 10,
2025, which is the fifth business day following the date hereof (such settlement cycle being referred to as “T+5”). Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in
the secondary market are generally required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade such Notes more than one business day prior to the scheduled
settlement date will be required, by virtue of the fact that the Notes initially will settle in T+5, to specify an alternative settlement arrangement at the time of any such trade to prevent failed settlement. Purchasers of such Notes who wish to
trade Notes prior to the date of delivery should consult their advisors. |
The Issuer has filed a registration statement (File No. 333-285481) (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus
in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC’s website at
www.sec.gov. Alternatively, the Issuer or any underwriter participating in this offering can arrange to send you the prospectus supplement and accompanying prospectus if you request it by calling Barclays Capital Inc. toll free at 1-888-603-5847, by calling J.P. Morgan Securities LLC collect at 1-212-834-4533, or by calling Wells Fargo Securities, Inc. toll free at
1-800-645-3751.
2
CME (NASDAQ:CME)
Historical Stock Chart
From Feb 2025 to Mar 2025
CME (NASDAQ:CME)
Historical Stock Chart
From Mar 2024 to Mar 2025
